CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 205 filers reported holding CHEMOCENTRYX INC in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $427,000 | +556.9% | 8,272 | +216.2% | 0.00% | – |
| Q2 2022 | $65,000 | -7.1% | 2,616 | 0.0% | 0.00% | – |
| Q1 2022 | $70,000 | -26.3% | 2,616 | 0.0% | 0.00% | – |
| Q4 2021 | $95,000 | +69.6% | 2,616 | -19.7% | 0.00% | – |
| Q3 2021 | $56,000 | +27.3% | 3,257 | 0.0% | 0.00% | – |
| Q2 2021 | $44,000 | -73.5% | 3,257 | 0.0% | 0.00% | – |
| Q1 2021 | $166,000 | -5.1% | 3,257 | +14.8% | 0.00% | – |
| Q4 2020 | $175,000 | +12.9% | 2,837 | 0.0% | 0.00% | – |
| Q3 2020 | $155,000 | -4.3% | 2,837 | 0.0% | 0.00% | – |
| Q2 2020 | $162,000 | +40.9% | 2,837 | 0.0% | 0.00% | – |
| Q1 2020 | $115,000 | +3.6% | 2,837 | 0.0% | 0.00% | – |
| Q4 2019 | $111,000 | +113.5% | 2,837 | -48.7% | 0.00% | – |
| Q2 2019 | $52,000 | – | 5,527 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |